Using AI to Create New Parkinson’s Treatments: Q&A with Mattias Alder
Alder, CEO of Gain Therapeutics, discusses how the Magellan platform was used in the creation of GT-02287.
October 26, 2026
Alder, CEO of Gain Therapeutics, discusses how the Magellan platform was used in the creation of GT-02287.